Amplatzer Talisman PFO Occluder

Next-generation patent foramen ovale closure device (FDA approved 2022) built on the original Amplatzer PFO Occluder frame, paired with a new, more flexible delivery sheath for easier deployment and repositioning to prevent recurrent ischemic stroke from paradoxical embolism.

FDA approval

2022